Related Experiment Video
Updated: Jan 29, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
Published on: June 3, 2016
HIF-1-regulated glucose metabolism in the control of apoptosis signaling
1a University Children's Hospital, Eythstr. 24, D-89075 Ulm, Germany. simone.fulda@uniklinik-ulm.de.
Abstract:
Resistance of human cancers to current treatment approaches remains a major concern in oncology. Therefore, much effort has been focused on identifying molecular pathways that are responsible for primary or acquired resistance of cancers in order to overcome resistance. Hypoxia is one of the hallmarks of solid tumors and usually correlates with poor prognosis. Under hypoxic conditions, cancer cells undergo a variety of adoptive changes, including the activation of signaling pathways, which promote cancer cell survival and block cell death. Hypoxia inducible factor (HIF)-1 is the key transcription factor that mediates adaptation of cancer cells to the hypoxic environment. There is increasing evidence that HIF-1 promotes tumor growth, at least in part, by upregulating genes that are involved in cellular energy metabolism. Thus, HIF-1 and hypoxia-inducible genes represent attractive targets for the design of molecular targeted therapies, which may offer new therapeutic options for a wide range of malignancies.
Insights
Cancer cells resist treatment partly due to hypoxia, a low-oxygen state. Targeting Hypoxia-inducible factor (HIF)-1 and its related genes may overcome this resistance and improve cancer therapies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Cancer treatment resistance is a significant clinical challenge.
- Hypoxia, a hallmark of solid tumors, is linked to poor patient prognosis.
- Hypoxia induces adaptive cellular changes that promote cancer cell survival and inhibit cell death.
Purpose of the Study:
- To investigate the role of Hypoxia-inducible factor (HIF)-1 in mediating cancer cell adaptation to hypoxic conditions.
- To explore HIF-1's contribution to tumor growth through the regulation of energy metabolism genes.
- To identify HIF-1 and hypoxia-inducible genes as potential targets for novel cancer therapies.
Main Methods:
- Analysis of molecular pathways involved in cancer resistance.
- Investigation of cellular responses under hypoxic conditions.
- Focus on the role of Hypoxia-inducible factor (HIF)-1 signaling.
Main Results:
- Hypoxia-inducible factor (HIF)-1 is identified as a key transcription factor in cancer cell adaptation to hypoxia.
- HIF-1 activation promotes tumor growth by upregulating genes involved in cellular energy metabolism.
- Hypoxia-inducible genes play a crucial role in cancer cell survival under low-oxygen stress.
Conclusions:
- Hypoxia-inducible factor (HIF)-1 is a critical mediator of cancer cell adaptation and survival in hypoxic tumors.
- Targeting HIF-1 and its downstream genes offers a promising strategy for overcoming treatment resistance.
- These molecular targets may lead to new therapeutic options for various malignancies.
Related Concept Videos
Glucose Homeostasis: Regulation of Blood Glucose
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Regulation of Metabolism
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Apoptosis
Interpreting ¹H NMR Signal Splitting: The (n + 1) Rule

